Forvard P/S multiplikatori: sxtchina.com (SXTC)

Ommaviy kompaniya China SXT Pharmaceuticals (SXTC) logotipi

China SXT Pharmaceuticals (SXTC) o'zining dorixona tarmog'ini kengaytirmoqda va an'anaviy Xitoy tibbiyotini global miqyosda targ'ib qilish uchun o'simliklardan tayyorlanadigan dori vositalari ishlab chiqarishni modernizatsiya qilmoqda. GURU.Markets dinamik grafigidagi forward P/S tarixi ushbu tendentsiyalarni aks ettiradi, bunda 0.30 metrikaning joriy qiymatini ifodalaydi. Muvaffaqiyat Xitoy Xalq Respublikasidagi sifat va distribyutsiya standartlariga rioya qilishga asoslangan, garchi daromadlar yetishmovchiligi va R&D xarajatlari pul oqimiga sezilarli bosim yaratayotgan bo'lsa-da.

SXT Pharmaceuticals - SXTC Kapitalizatsiyaning kutilayotgan sotuvga nisbati (davr: 04.07.2022 - 16.11.2026)

SXT China (SXTC) kompaniyasi koʻrsatkichlari kesimi va tahlili

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahlili:SXTC (SXT Pharmaceuticals)
SXT Pharmaceuticals tovar namunasi

China SXT Pharmaceuticals (SXTC) kompaniyasidagi investitsiya xatarlarini forward P/S koeffitsienti orqali tahlil qilish talab etiladi, u joriy biznes qiymatini prognoz qilingan daromadlar bilan solishtirish orqali kotirovkalardagi shovqinlarni bartaraf etadi. Hukumat nazorati bilan cheklangan an'anaviy dori ishlab chiqaruvchi uchun ushbu grafik distributsiyani kengaytirish samaradorligining bozor tomonidan real vaqt rejimida baholanishini aks ettiradi va investorlarga makroiqtisodiy likvidlik hamda foiz stavkalarini hisobga olgan holda aktivning adolatli qiymatini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati MannKind Corp (MNKD)|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TBPH|AQST (Aquestive Corp) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori scPharmaceuticals Inc. (SCPH)|Forvard narx/daromad multiplikatori TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Sotuvga nisbatan forvard narx BHST|Invizyne Technologies - Forvard P/S multiplikatori|oramed.com (ORMP) - Forvard narx/daromad multiplikatori|ENTX (enterabio.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HYFT|ABVC (ABVC BioPharma, Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori cumberlandpharma.com|Narxning prognoz qilingan daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori TELO (telomirpharma.com)|RANI - Forvard narx/daromad multiplikatori|SNYR - Narxning prognoz qilingan daromadga nisbati|rallybio.com - Narxning kutilayotgan daromadga nisbati|LEXX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aptorum Group Limited APM|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics (LYRA)|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP